摘要
目的观察倍他乐克治疗慢性充血性心力衰竭的疗效与安全性。方法入选71例心脏病伴轻、中度慢性充血性心力衰竭的患者,将其随机分为治疗组(n=36)和对照组(n=35)。对照组接受常规抗心力衰竭治疗;治疗组在常规治疗基础上加服倍他乐克,共治疗12周。治疗前后观察两组患者的心率、多普勒超声心动图检查左室射血分数(LVEF)、左室舒张末压内径(LVDd)及心功能情况。结果治疗组显效28例,占77.8%;有效6例,占16.7%;无效2例,占6.5%;总有效率为94.4%。对照组显效16例,占45.7%;有效10例,占28.6%;无效9例,占25.7%;总有效率为74.3%。治疗后两组之间的总有效率、心率和心功能差异均有统计学意义(P<0.05)。结论在接受心力衰竭常规治疗基础上加服倍他乐克对改善心力衰竭症状具有良好效果。
Objective To observe the curative effect and safety of Betaloc in treating patients with chronic congestive heart failure. Methods 71 cases with cardiac diseases complicated with slight or moderate chronic congestive heart failure were randomly divided into 2 groups： treatment group and control group; routine anti- heart failure treatment was given to control group while the routine treatment plus Betaloe was given to treatment group; the heart rate,LVEF,LVDd and heart function of the patients in Both groups before and after treatment were observed. Results The difference in total effective rate, heart rate and heart function between the 2 groups was of statistical significance. Conclusion The routine treatment plus Betaloe has good effect in improving the symptoms of heart failure.
出处
《西南军医》
2008年第1期30-31,共2页
Journal of Military Surgeon in Southwest China
